H.C. Wainwright lowered the firm’s price target on Zura Bio (ZURA) to $2 from $3 and keeps a Neutral rating on the shares. The firm updated the company’s model post the Q2 report to reflect increases in potentially dilutive shares outstanding.
Claim 70% Off TipRanks This Holiday Season
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ZURA: